Abstract:5539 Previous studies have suggested that the sphingosine kinase 1 (SPHK1) gene can act as an oncogene, mediating various cellular functions such as cell proliferation, apoptosis inhibition and cell transformation and migration. The current study was conducted to investigate the expression of SPHK1 in human astrocytomas and to characterize its association with the clinical progression of astrocytomas. Our results of Western blotting and RT-PCR showed that SPHK1 mRNA and protein were upregulated in astrocytoma cell lines, as well as in astrocytoma tissues when compared with paired adjacent non-cancerous tissues from the same patients. In addition, 243 paraffin-embedded archival astrocytoma tissues were examined with immunohistochemical staining, among which 227 paraffin-embedded archival astrocytomas biopsies displayed moderate to strong cytoplasmic staining of SPHK1 in astrocytomas cells, whereas no significant staining of SPHK1 was detected in the adjacent non-cancerous epithelial cells. These data supported the notion that SPHK1 might play a role in the development and progression of astrocytomas. Quantitative SPHK1 immunohistochemical staining demonstrated that the SPHK1 expression level increased in parallel with the development and progression of astrocytomas. Further analysis of the relationship between SPHK1 staining and the clinical characteristics of patients showed a significant correlation of SPHK1 expression with the clinocopathological staging, while it was not correlated to the age and gender in astrocytomas patients, strongly suggesting that SPHK1 might be useful as an independent marker to identify subsets of astrocytomas patients with more aggressive disease. Furthermore, patients with high SPHK1 expression revealed a cumulative 3-year survival rate of 10.3% (n=100, 95% confidence interval, 0.041-0.165), as compared with the 57.7% (95% confidence interval, 0.517-0.637) cumulative 3-year survival rate in the low SPHK1 group (n =143), suggesting the possibility to use SPHK1 as a predictor for patient prognosis and survival. It is also noteworthy that the predictive significance of SPHK1 expression for poorer prognosis was identified in both relatively early- (grade I and II) and late-stage (grade III and IV) patient subgroups. Taken together, our data strongly suggest the usefulness of SPHK1 expression as a prognostic marker for astrocytoma patients.

Prognostic Significance Of Integrin-Linked Kinase1 Overexpression In Astrocytoma

The Expression of CD44s and Mib-1 in Astrocytomas and Their Clinical Significance

The Clinical Significance of Sphk1 Expression in Human Astrocytomas Progression and Overall Patient Survival

Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival

Overexpression of Integrin-Linked Kinase (ILK) is Associated with Tumor Progression and an Unfavorable Prognosis in Patients with Colorectal Cancer

The Expression and Prognostic Value of ILK and YAP1 in Glioma.

Significance of Integrin-Linked Kinase (ILK) in Tumorigenesis and Its Potential Implication As a Biomarker and Therapeutic Target for Human Cancer.

High Expression of Integrin-Linked Kinase Predicts Aggressiveness and Poor Prognosis in Patients with Gastric Cancer.

Expression of Ubiquitin Conjugating Enzyme UbcH10 in Brain Astrocytomas

Acylglycerol Kinase Functions As an Oncogene and an Unfavorable Prognostic Marker of Human Gliomas.

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

Clinical Significance of Astrocyte Elevated Gene-1 Expression in Human Oligodendrogliomas

Elevated Levels of P-Mnk1, P-Eif4e and P-P70s6k Proteins Are Associated with Tumor Recurrence and Poor Prognosis in Astrocytomas.

The expression and significance of IKKε gene in Human gliomas

The Expression of P57kip2 and P27kip1 in Human Brain Astrocytoma and the Prognostic Significance

Over-Expression of Cofilin-1 and Phosphoglycerate Kinase 1 in Astrocytomas Involved in Pathogenesis of Radioresistance

Study on the expression of AEG-1 and its clinical significance in the astrocytomas of different grades

Expression and Significance of LRIG1 Gene in Human Astrocytomas

Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.

Expression of Integrin-Linked Kinase in Human Bladder Transitional Cell Carcinoma and the Related Significance

IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-κB.